MA45274A - Préparations améliorées de cellules progénitrices hépatiques adultes - Google Patents

Préparations améliorées de cellules progénitrices hépatiques adultes

Info

Publication number
MA45274A
MA45274A MA045274A MA45274A MA45274A MA 45274 A MA45274 A MA 45274A MA 045274 A MA045274 A MA 045274A MA 45274 A MA45274 A MA 45274A MA 45274 A MA45274 A MA 45274A
Authority
MA
Morocco
Prior art keywords
progenitor cell
cell preparations
hepatic progenitor
adult hepatic
improved adult
Prior art date
Application number
MA045274A
Other languages
English (en)
Inventor
Pierre-Edouard Dollet
Catherine Lombard
Mustapha Najimi
Etienne Sokal
Original Assignee
Univ Catholique Louvain
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Publication date
Publication of MA45274A publication Critical patent/MA45274A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/407—Liver; Hepatocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/067—Hepatocytes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5067—Liver cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/14—Coculture with; Conditioned medium produced by hepatocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2531/00—Microcarriers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Analytical Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Diabetes (AREA)
  • Developmental Biology & Embryology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Virology (AREA)
MA045274A 2016-03-02 Préparations améliorées de cellules progénitrices hépatiques adultes MA45274A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP16158327 2016-03-02

Publications (1)

Publication Number Publication Date
MA45274A true MA45274A (fr) 2019-01-09

Family

ID=55696855

Family Applications (1)

Application Number Title Priority Date Filing Date
MA045274A MA45274A (fr) 2016-03-02 Préparations améliorées de cellules progénitrices hépatiques adultes

Country Status (14)

Country Link
US (1) US20190046584A1 (fr)
EP (1) EP3423566A1 (fr)
JP (1) JP2019506890A (fr)
KR (1) KR20180114073A (fr)
CN (1) CN108779440A (fr)
AU (1) AU2017225825A1 (fr)
BR (1) BR112018067597A8 (fr)
CA (1) CA3013427A1 (fr)
EA (1) EA039743B1 (fr)
IL (1) IL261383A (fr)
MA (1) MA45274A (fr)
MX (1) MX2018010508A (fr)
SG (1) SG11201807041PA (fr)
WO (1) WO2017149059A1 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6474394B2 (ja) 2013-07-05 2019-02-27 ユニベルシテ カトリック ドゥ ルーベン ヒト成体肝臓幹細胞由来の馴化培地および肝臓障害の治療におけるその使用
EA202191673A1 (ru) 2018-12-14 2021-09-28 Прометера Терапьютикс Са Композиция на основе клеток, содержащая клетки-предшественники печени, экспрессирующие hla-e
TW202035682A (zh) 2018-12-14 2020-10-01 比利時商普羅米修亞生物科技股份有限公司 表現hla-g之肝先驅細胞及取得包含該等細胞之此等細胞組成物之方法與其用途
TW202100170A (zh) * 2019-03-26 2021-01-01 比利時商普羅米修亞生物科技股份有限公司 用於治療慢性肝衰竭之急性發作的成人肝先驅細胞
US20220202874A1 (en) 2019-03-26 2022-06-30 Promethera Therapeutics Sa Adult Liver Progenitor Cells for Treating Non-Alcoholic Fatty Liver Disease
JP2022530620A (ja) 2019-04-30 2022-06-30 プロメセラ セラピューティクス エスエイ ヒト同種肝臓由来前駆細胞の調製
WO2020221842A1 (fr) 2019-04-30 2020-11-05 Promethera Biosciences S.A./N.V. Préparation de cellules progénitrices allogéniques humaines dérivées du foie
EP4041261A1 (fr) 2019-10-09 2022-08-17 Cellaion SA Utilisation de cellules souches ou progénitrices hépatiques, de leurs lysats et/ou de milieu conditionné dans des troubles caractérisés par une hyperperméabilité vasculaire
EP3881853A1 (fr) 2020-03-20 2021-09-22 Promethera Therapeutics Sa Cellules progénitrices allogéniques humaines dérivées du foie à utiliser dans le traitement des maladies pulmonaires inflammatoires et infectieuses et de l'inflammation systémique
CN111778268B (zh) * 2020-06-03 2022-06-21 武汉仝干医疗科技股份有限公司 增强解毒功能基因片段及改造的HepG2细胞
WO2023180122A1 (fr) 2022-03-24 2023-09-28 Université Catholique de Louvain Utilisation de cellules progénitrices allogéniques humaines dérivées du foie pour traiter et/ou prévenir la sénescence cellulaire
WO2024200809A1 (fr) 2023-03-31 2024-10-03 Université Catholique de Louvain Utilisation de cellules progénitrices allogéniques humaines dérivées du foie pour traiter et/ou prévenir le carcinome hépatocellulaire
EP4560009A1 (fr) 2023-11-27 2025-05-28 Cellaïon SA Procédé de préparation de cellules isolées dérivées du foie

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006126219A1 (fr) * 2005-05-26 2006-11-30 Fresenius Medical Care Deutschland G.M.B.H. Cellules progeniteurs hepatiques
ES2359874T5 (es) * 2005-12-21 2014-12-12 Universite Catholique De Louvain Células madre hepáticas aisladas
DE602006020071D1 (de) 2005-12-21 2011-03-24 Univ Catholique Louvain Isolierte leberstammzellen
US20110104126A1 (en) * 2008-05-14 2011-05-05 Public University Corporation Yokohama City Univer Human Hepatic Stem Cell, Method for Preparation of the Same, Method for Induction of Differentiation of the Same, and Method for Utilization of the Same
US8415149B2 (en) * 2010-05-06 2013-04-09 Gwo Xi Stem Cell Applied Technology Co., Ltd. Hepatic progenitor cells and uses thereof
WO2013110354A1 (fr) * 2012-01-25 2013-08-01 Université Catholique de Louvain Compositions et procédés de transplantation de cellules
JP6474394B2 (ja) 2013-07-05 2019-02-27 ユニベルシテ カトリック ドゥ ルーベン ヒト成体肝臓幹細胞由来の馴化培地および肝臓障害の治療におけるその使用
WO2015028577A1 (fr) * 2013-08-28 2015-03-05 Promethera Biosciences S.A./N.V. Procédé de production de cellules progénitrices de foie adulte

Also Published As

Publication number Publication date
JP2019506890A (ja) 2019-03-14
BR112018067597A8 (pt) 2019-10-15
CN108779440A (zh) 2018-11-09
AU2017225825A1 (en) 2018-08-16
US20190046584A1 (en) 2019-02-14
KR20180114073A (ko) 2018-10-17
BR112018067597A2 (pt) 2019-01-08
EA201891913A1 (ru) 2019-02-28
WO2017149059A1 (fr) 2017-09-08
EP3423566A1 (fr) 2019-01-09
EA039743B1 (ru) 2022-03-05
MX2018010508A (es) 2018-11-09
CA3013427A1 (fr) 2017-09-08
IL261383A (en) 2018-10-31
SG11201807041PA (en) 2018-09-27

Similar Documents

Publication Publication Date Title
HUE053101T2 (hu) Javított T-sejt-készítmények
IL262359A (en) Ex vivo bite-activated t cells
EP3858365C0 (fr) Lymphocytes t car optimisés avec de l'or
EP3320082A4 (fr) Administration de substances à des cellules anucléées
IL261383A (en) Improved preparations of adult human liver stem cells
HUE056133T2 (hu) Fuzionált pentaciklusos imidazol-származékok
DK3132034T3 (da) Terapeutikum
HUE046262T2 (hu) Sejt
EP3444295A4 (fr) Membrane bipolaire
DK3113883T3 (da) Cellesorteringssystem der anvender mikrofremstillede komponenter
EP3472305A4 (fr) Cellules treg génétiquement modifiées
IL249298A0 (en) Immuno-modulatory progenitor (imp) cells
DK3455344T3 (da) Hæmatopoietiske stam-/Progenitorceller
HUE058288T2 (hu) Pridopidin módosított hatóanyag-leadású készítményei
DK3223829T3 (da) Behandling af sygdomme associeret med hepatisk stellat-celleaktivering under anvendelse af ammoniak-sænkende terapier
HRP20181479T1 (hr) Tekući farmaceutski sastav
EP3498410A4 (fr) Structure de jonction
PL3151327T3 (pl) Roztwór elektrolitu
IL252618B (en) Biomolecule conjugates containing a maytansinoid
PT3264956T (pt) Conjunto de taça
DK3427323T3 (da) Brændselscelle
DK3489290T3 (da) Kompositmembran
ES2914082T8 (es) Procedimiento de generación de progenitores de células T
DK3365107T3 (da) Cellekultur
DK3177388T3 (da) Membran